{
  "antibiotics": [
    {
      "id": "amoxicillin",
      "name": "Amoxicillin",
      "class": "Penicillin",
      "spectrum": "Gram-positive, some Gram-negative",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["250mg", "500mg", "875mg", "125mg/5mL", "250mg/5mL", "400mg/5mL"]
        }
      ],
      "adult_dosing": {
        "standard": "500mg PO TID",
        "high_dose": "1g PO TID",
        "max_daily": "3g"
      },
      "pediatric_dosing": {
        "standard": "40-50mg/kg/day divided TID",
        "high_dose": "75-90mg/kg/day divided TID",
        "max_daily": "Based on weight"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "Adjust for severe renal impairment (CrCl <30mL/min)",
        "Common side effects: diarrhea, rash"
      ]
    },
    {
      "id": "amoxicillin-clavulanate",
      "name": "Amoxicillin-Clavulanate",
      "class": "Penicillin + Beta-lactamase inhibitor",
      "spectrum": "Gram-positive, Gram-negative, anaerobes",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["500/125mg", "875/125mg", "200/28.5mg/5mL", "400/57mg/5mL"]
        }
      ],
      "adult_dosing": {
        "standard": "500/125mg PO TID or 875/125mg PO BID",
        "high_dose": "875/125mg PO BID",
        "max_daily": "4g amoxicillin component"
      },
      "pediatric_dosing": {
        "standard": "40-50mg/kg/day of amoxicillin component divided BID-TID",
        "high_dose": "90mg/kg/day of amoxicillin component divided BID",
        "max_daily": "Based on weight"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "Adjust for renal impairment",
        "Higher risk of diarrhea than amoxicillin alone",
        "Use high-dose formulation to limit clavulanate (less GI side effects)"
      ]
    },
    {
      "id": "ceftriaxone",
      "name": "Ceftriaxone",
      "class": "Third-generation Cephalosporin",
      "spectrum": "Broad-spectrum, Gram-positive and Gram-negative",
      "formulations": [
        {
          "form": "injection",
          "strengths": ["250mg", "500mg", "1g", "2g"]
        }
      ],
      "adult_dosing": {
        "standard": "1-2g IV/IM daily",
        "high_dose": "2g IV q12h (meningitis)",
        "max_daily": "4g"
      },
      "pediatric_dosing": {
        "standard": "50-75mg/kg/day IV/IM divided q12-24h",
        "high_dose": "100mg/kg/day IV divided q12h (meningitis)",
        "max_daily": "4g"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "No dosage adjustment for renal impairment",
        "Caution with hyperbilirubinemic neonates",
        "May cause biliary sludging with prolonged use"
      ]
    },
    {
      "id": "vancomycin",
      "name": "Vancomycin",
      "class": "Glycopeptide",
      "spectrum": "Gram-positive including MRSA",
      "formulations": [
        {
          "form": "injection",
          "strengths": ["500mg", "1g", "1.5g", "10g"]
        },
        {
          "form": "oral",
          "strengths": ["125mg", "250mg"]
        }
      ],
      "adult_dosing": {
        "standard": "15-20mg/kg IV q8-12h (actual body weight)",
        "high_dose": "25-30mg/kg IV loading dose, then 15-20mg/kg q8-12h",
        "max_daily": "Based on levels, typically 4g",
        "oral": "125mg PO QID (C. difficile)"
      },
      "pediatric_dosing": {
        "standard": "40-60mg/kg/day IV divided q6-8h",
        "high_dose": "60mg/kg/day IV divided q6h (meningitis)",
        "max_daily": "Based on levels",
        "oral": "40mg/kg/day PO divided QID (C. difficile), max 2g/day"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "Requires therapeutic drug monitoring",
        "Adjust for renal impairment",
        "IV administration may cause Red Man Syndrome (infuse over at least 60 min)",
        "Oral formulation only effective for C. difficile infection (not absorbed)"
      ]
    },
    {
      "id": "azithromycin",
      "name": "Azithromycin",
      "class": "Macrolide",
      "spectrum": "Gram-positive, atypical pathogens, some Gram-negative",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["250mg", "500mg", "600mg", "200mg/5mL"]
        },
        {
          "form": "injection",
          "strengths": ["500mg"]
        }
      ],
      "adult_dosing": {
        "standard": "500mg PO day 1, then 250mg PO daily for 4 days",
        "high_dose": "500mg PO daily for 3 days",
        "max_daily": "500mg",
        "respiratory": "500mg PO daily for 3 days",
        "STI": "1g PO single dose (chlamydia)"
      },
      "pediatric_dosing": {
        "standard": "10mg/kg PO day 1 (max 500mg), then 5mg/kg PO daily for 4 days (max 250mg)",
        "high_dose": "10mg/kg/day PO for 3 days (max 500mg/day)",
        "max_daily": "500mg",
        "otitis": "30mg/kg PO single dose (max 1.5g)"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "No dosage adjustment for renal impairment",
        "QT interval prolongation risk",
        "Drug interactions with statins, warfarin, and other QT-prolonging drugs",
        "Take on empty stomach or with food, but not with antacids"
      ]
    },
    {
      "id": "ciprofloxacin",
      "name": "Ciprofloxacin",
      "class": "Fluoroquinolone",
      "spectrum": "Gram-negative, some Gram-positive",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["250mg", "500mg", "750mg"]
        },
        {
          "form": "injection",
          "strengths": ["200mg", "400mg"]
        }
      ],
      "adult_dosing": {
        "standard": "500mg PO BID or 400mg IV q12h",
        "high_dose": "750mg PO BID or 400mg IV q8h",
        "max_daily": "1.5g PO or 1.2g IV",
        "UTI": "250-500mg PO BID for 3-7 days (uncomplicated)",
        "respiratory": "750mg PO BID for 7-14 days"
      },
      "pediatric_dosing": {
        "standard": "20-30mg/kg/day PO divided BID (max 1.5g/day)",
        "high_dose": "30mg/kg/day IV divided q8-12h (max 1.2g/day)",
        "max_daily": "1.5g PO or 1.2g IV",
        "note": "Not first-line in pediatrics due to potential for cartilage damage"
      },
      "special_considerations": [
        "Pregnancy category C - avoid if possible",
        "Adjust for renal impairment",
        "Reserve as last-line therapy due to resistance concerns and adverse effects",
        "Risk of tendinitis/tendon rupture, peripheral neuropathy, CNS effects",
        "Avoid in children/adolescents if possible",
        "Take 2 hours apart from antacids, iron, calcium, zinc"
      ]
    },
    {
      "id": "nitrofurantoin",
      "name": "Nitrofurantoin",
      "class": "Nitrofuran",
      "spectrum": "Common uropathogens (E. coli, Enterococcus, Staphylococcus)",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["50mg", "100mg", "25mg/5mL"]
        }
      ],
      "adult_dosing": {
        "standard": "100mg PO BID",
        "macrocrystal": "100mg PO BID",
        "monohydrate/macrocrystal": "100mg PO BID",
        "max_daily": "200mg",
        "UTI": "100mg PO BID for 5 days (uncomplicated cystitis)"
      },
      "pediatric_dosing": {
        "standard": "5-7mg/kg/day PO divided QID (max 400mg/day)",
        "macrocrystal": "5-7mg/kg/day PO divided QID",
        "max_daily": "400mg"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe, avoid at term (36+ weeks)",
        "Contraindicated if CrCl <30mL/min",
        "Contraindicated in G6PD deficiency",
        "Take with food to improve absorption and reduce GI upset",
        "May cause pulmonary toxicity with long-term use",
        "Urine may turn brown-yellow"
      ]
    },
    {
      "id": "trimethoprim-sulfamethoxazole",
      "name": "Trimethoprim-Sulfamethoxazole (TMP-SMX)",
      "class": "Folate antagonist",
      "spectrum": "Gram-positive and Gram-negative, including MRSA",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["80/400mg (SS)", "160/800mg (DS)", "40/200mg per 5mL"]
        },
        {
          "form": "injection",
          "strengths": ["80/400mg per 5mL"]
        }
      ],
      "adult_dosing": {
        "standard": "1-2 DS tablets PO BID",
        "high_dose": "5mg/kg TMP component IV q8h",
        "max_daily": "320mg TMP component",
        "UTI": "1 DS tablet PO BID for 3 days (uncomplicated cystitis)",
        "MRSA": "1-2 DS tablets PO BID"
      },
      "pediatric_dosing": {
        "standard": "8-12mg/kg/day TMP component PO/IV divided BID",
        "high_dose": "15-20mg/kg/day TMP component PO/IV divided q6-8h (severe infections)",
        "max_daily": "320mg TMP component",
        "UTI": "8mg/kg/day TMP component PO divided BID for 3-5 days"
      },
      "special_considerations": [
        "Pregnancy category C - avoid in first trimester and near term",
        "Adjust for renal impairment",
        "Contraindicated if CrCl <15mL/min",
        "Monitor for rash, bone marrow suppression, hyperkalemia",
        "Drug interactions with warfarin, phenytoin, methotrexate",
        "Ensure adequate hydration"
      ]
    },
    {
      "id": "metronidazole",
      "name": "Metronidazole",
      "class": "Nitroimidazole",
      "spectrum": "Anaerobes, protozoa",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["250mg", "500mg"]
        },
        {
          "form": "injection",
          "strengths": ["500mg"]
        }
      ],
      "adult_dosing": {
        "standard": "500mg PO/IV TID",
        "high_dose": "500mg PO/IV q6h",
        "max_daily": "4g",
        "C. difficile": "500mg PO TID for 10-14 days",
        "anaerobic": "500mg PO/IV TID for 7-10 days"
      },
      "pediatric_dosing": {
        "standard": "30mg/kg/day PO/IV divided TID (max 2g/day)",
        "high_dose": "40mg/kg/day PO/IV divided TID (max 4g/day)",
        "max_daily": "4g",
        "C. difficile": "30mg/kg/day PO divided TID for 10 days (max 2g/day)"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "No significant dosage adjustment for renal impairment",
        "Disulfiram-like reaction with alcohol (avoid alcohol during and for 3 days after)",
        "May cause metallic taste, neuropathy with prolonged use",
        "Drug interactions with warfarin, lithium, phenytoin"
      ]
    },
    {
      "id": "piperacillin-tazobactam",
      "name": "Piperacillin-Tazobactam",
      "class": "Penicillin + Beta-lactamase inhibitor",
      "spectrum": "Broad-spectrum, including Pseudomonas",
      "formulations": [
        {
          "form": "injection",
          "strengths": ["2.25g", "3.375g", "4.5g"]
        }
      ],
      "adult_dosing": {
        "standard": "3.375g IV q6h or 4.5g IV q8h",
        "high_dose": "4.5g IV q6h",
        "max_daily": "18g piperacillin component",
        "extended_infusion": "4.5g IV q8h (infused over 4 hours)"
      },
      "pediatric_dosing": {
        "standard": "300mg/kg/day piperacillin component IV divided q6-8h (max 16g/day)",
        "high_dose": "400mg/kg/day piperacillin component IV divided q6-8h (max 18g/day)",
        "max_daily": "18g piperacillin component"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "Adjust for renal impairment",
        "Extended infusion may improve efficacy for serious infections",
        "Monitor for hypokalemia, neutropenia with prolonged use",
        "Higher sodium content than other antibiotics"
      ]
    },
    {
      "id": "meropenem",
      "name": "Meropenem",
      "class": "Carbapenem",
      "spectrum": "Very broad-spectrum, including ESBL-producing organisms",
      "formulations": [
        {
          "form": "injection",
          "strengths": ["500mg", "1g"]
        }
      ],
      "adult_dosing": {
        "standard": "1g IV q8h",
        "high_dose": "2g IV q8h (meningitis)",
        "max_daily": "6g",
        "extended_infusion": "1g IV q8h (infused over 3 hours)"
      },
      "pediatric_dosing": {
        "standard": "60mg/kg/day IV divided q8h (max 3g/day)",
        "high_dose": "120mg/kg/day IV divided q8h (meningitis, max 6g/day)",
        "max_daily": "6g"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "Adjust for renal impairment",
        "Reserve for serious infections due to resistance concerns",
        "Lower seizure risk than imipenem",
        "Extended infusion may improve efficacy for serious infections"
      ]
    },
    {
      "id": "doxycycline",
      "name": "Doxycycline",
      "class": "Tetracycline",
      "spectrum": "Broad-spectrum, atypical pathogens, MRSA",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["50mg", "75mg", "100mg", "200mg"]
        },
        {
          "form": "injection",
          "strengths": ["100mg"]
        }
      ],
      "adult_dosing": {
        "standard": "100mg PO/IV BID day 1, then 100mg PO/IV daily or BID",
        "high_dose": "100mg PO/IV BID",
        "max_daily": "200mg",
        "respiratory": "100mg PO BID for 5-7 days",
        "MRSA": "100mg PO BID"
      },
      "pediatric_dosing": {
        "standard": "For children >8 years: 4mg/kg/day PO/IV divided BID day 1, then 2-4mg/kg/day divided daily-BID",
        "high_dose": "For children >8 years: 4mg/kg/day PO/IV divided BID",
        "max_daily": "200mg",
        "note": "Generally avoided in children <8 years due to dental staining"
      },
      "special_considerations": [
        "Pregnancy category D - contraindicated",
        "No dosage adjustment for renal impairment",
        "Avoid in children <8 years (dental staining)",
        "Take with full glass of water, avoid lying down for 30 minutes",
        "Photosensitivity risk",
        "Decreased efficacy with calcium, iron, antacids, dairy products"
      ]
    },
    {
      "id": "cephalexin",
      "name": "Cephalexin",
      "class": "First-generation Cephalosporin",
      "spectrum": "Gram-positive, limited Gram-negative",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["250mg", "500mg", "125mg/5mL", "250mg/5mL"]
        }
      ],
      "adult_dosing": {
        "standard": "500mg PO QID",
        "high_dose": "1g PO QID",
        "max_daily": "4g",
        "cellulitis": "500mg PO QID for 5-7 days",
        "UTI": "500mg PO QID for 7-14 days"
      },
      "pediatric_dosing": {
        "standard": "25-50mg/kg/day PO divided QID (max 4g/day)",
        "high_dose": "75-100mg/kg/day PO divided QID (max 4g/day)",
        "max_daily": "4g",
        "UTI": "50mg/kg/day PO divided QID for 7-14 days"
      },
      "special_considerations": [
        "Pregnancy category B - generally safe",
        "Adjust for severe renal impairment",
        "Alternative for patients with non-anaphylactic penicillin allergy",
        "Generally well-tolerated"
      ]
    },
    {
      "id": "clindamycin",
      "name": "Clindamycin",
      "class": "Lincosamide",
      "spectrum": "Gram-positive, anaerobes",
      "formulations": [
        {
          "form": "oral",
          "strengths": ["150mg", "300mg", "75mg/5mL"]
        },
        {
          "form": "injection",
          "strengths": ["150mg/mL", "300mg/2mL", "600mg/4mL", "900mg/6mL"]
        }
      ],
      "adult_dosing": {
        "standard": "300-450mg PO QID or 600mg IV q8h",
        "high_dose": "600-900mg IV q8h",
        "max_daily": "2.7g IV or 1.8g PO",
        "MRSA": "300-450mg PO QID",
        "necrotizing": "600-900mg IV q8h (part of combination therapy)"
      },
      "pediatric_dosing": {
        "standard": "20-30mg/kg/day PO divided TID-QID (max 1.8g/
(Content truncated due to size limit. Use line ranges to read in chunks)